Novel Hybridized Computational Paradigms Integrated with Five Stand-Alone Algorithms for Clinical Prediction of HCV Status among Patients: A Data-Driven Technique.
artificial intelligence
clinical variables
hepatitis C status
hybrid paradigms
machine learning
Journal
Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444
Informations de publication
Date de publication:
27 Dec 2022
27 Dec 2022
Historique:
received:
17
10
2022
revised:
19
12
2022
accepted:
21
12
2022
entrez:
21
1
2023
pubmed:
22
1
2023
medline:
22
1
2023
Statut:
epublish
Résumé
The emergence of health informatics opens new opportunities and doors for different disease diagnoses. The current work proposed the implementation of five different stand-alone techniques coupled with four different novel hybridized paradigms for the clinical prediction of hepatitis C status among patients, using both sociodemographic and clinical input variables. Both the visualized and quantitative performances of the stand-alone algorithms present the capability of the Gaussian process regression (GPR), Generalized neural network (GRNN), and Interactive linear regression (ILR) over the Support Vector Regression (SVR) and Adaptive neuro-fuzzy inference system (ANFIS) models. Hence, due to the lower performance of the stand-alone algorithms at a certain point, four different novel hybrid data intelligent algorithms were proposed, including: interactive linear regression-Gaussian process regression (ILR-GPR), interactive linear regression-generalized neural network (ILR-GRNN), interactive linear regression-Support Vector Regression (ILR-SVR), and interactive linear regression-adaptive neuro-fuzzy inference system (ILR-ANFIS), to boost the prediction accuracy of the stand-alone techniques in the clinical prediction of hepatitis C among patients. Based on the quantitative prediction skills presented by the novel hybridized paradigms, the proposed techniques were able to enhance the performance efficiency of the single paradigms up to 44% and 45% in the calibration and validation phases, respectively.
Identifiants
pubmed: 36676028
pii: life13010079
doi: 10.3390/life13010079
pmc: PMC9866913
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
N Engl J Med. 2001 Nov 8;345(19):1368-77
pubmed: 11794169
Environ Sci Pollut Res Int. 2021 Aug;28(29):39139-39158
pubmed: 33751346
Turk J Chem. 2020 Oct 26;44(5):1339-1351
pubmed: 33488234
Brief Bioinform. 2017 Sep 1;18(5):851-869
pubmed: 27473064
In Silico Pharmacol. 2021 Apr 12;9(1):31
pubmed: 33928008
Water Sci Technol. 2018 Dec;78(10):2064-2076
pubmed: 30629534
Life (Basel). 2022 Sep 27;12(10):
pubmed: 36294943
Saudi J Biol Sci. 2022 Feb;29(2):1111-1117
pubmed: 35197780
IEEE J Biomed Health Inform. 2017 Jan;21(1):4-21
pubmed: 28055930
BMC Bioinformatics. 2015;16 Suppl 12:S4
pubmed: 26329995
Appl Soft Comput. 2021 May;103:107161
pubmed: 33584158
World J Gastroenterol. 2007 May 7;13(17):2436-41
pubmed: 17552026
J Sep Sci. 2021 Feb;44(4):843-849
pubmed: 33326699
J Chromatogr A. 2005 May 27;1076(1-2):163-9
pubmed: 15974083
Pac Symp Biocomput. 2018;23:192-203
pubmed: 29218881
Diagnostics (Basel). 2022 Dec 06;12(12):
pubmed: 36553067
PLoS One. 2020 Nov 5;15(11):e0242028
pubmed: 33152046
Results Phys. 2021 Aug;27:104509
pubmed: 34307005
Lancet Infect Dis. 2005 Sep;5(9):558-67
pubmed: 16122679
Brief Bioinform. 2006 Mar;7(1):86-112
pubmed: 16761367
AIDS. 2003 Mar 28;17(5):721-5
pubmed: 12646795
Anal Bioanal Chem. 2018 Dec;410(30):7931-7941
pubmed: 30361914
Molecules. 2022 Oct 12;27(20):
pubmed: 36296433
Int J Environ Res Public Health. 2022 Jan 10;19(2):
pubmed: 35055559
Sci Total Environ. 2023 Feb 1;858(Pt 2):159697
pubmed: 36334664